title: Fifth Conference on Retroviruses & Opportunistic Infections. Interview by Ron Baker.
authors.forename: S
authors.initials: S
authors.lastname: Follansbee
authors.forename: S
authors.initials: S
authors.lastname: Deeks
authors.forename: H
authors.initials: H
authors.lastname: Bartnoff
mesh_terms: D017088:AIDS-Related Opportunistic Infections / Q000517:prevention & control; D000480:Alkynes; D019380:Anti-HIV Agents / Q000009:adverse effects* / Q000600:supply & distribution / Q000627:therapeutic use*; D048588:Benzoxazines; D002219:Carbamates; D002986:Clinical Trials as Topic; D003226:Congresses as Topic; D003521:Cyclopropanes; D015224:Dideoxynucleosides / Q000009:adverse effects* / Q000600:supply & distribution / Q000627:therapeutic use*; D004352:Drug Resistance, Microbial; D004359:Drug Therapy, Combination; D015507:Drugs, Investigational; D005663:Furans; D005821:Genetic Techniques; D015658:HIV Infections / Q000188:drug therapy* / Q000635:transmission; D017320:HIV Protease Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D006918:Hydroxyurea / Q000627:therapeutic use; D010078:Oxazines / Q000627:therapeutic use; D018894:Reverse Transcriptase Inhibitors / Q000627:therapeutic use; D013449:Sulfonamides / Q000627:therapeutic use*; D019562:Viral Load / Q000379:methods*; D000099227:Abacavir
chemical_list: D000480:Alkynes; D019380:Anti-HIV Agents; D048588:Benzoxazines; D002219:Carbamates; D003521:Cyclopropanes; D015224:Dideoxynucleosides; D015507:Drugs, Investigational; D005663:Furans; D017320:HIV Protease Inhibitors; D006918:Hydroxyurea; D010078:Oxazines; D018894:Reverse Transcriptase Inhibitors; D013449:Sulfonamides; D000099227:Abacavir; C095108:amprenavir; C098320:efavirenz